IBDEI0X9 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33454,1,3,0)
 ;;=3^Anorexia
 ;;^UTILITY(U,$J,358.3,33454,1,4,0)
 ;;=4^R63.0
 ;;^UTILITY(U,$J,358.3,33454,2)
 ;;=^7939
 ;;^UTILITY(U,$J,358.3,33455,0)
 ;;=R87.611^^119^1580^2
 ;;^UTILITY(U,$J,358.3,33455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33455,1,3,0)
 ;;=3^ASC-H
 ;;^UTILITY(U,$J,358.3,33455,1,4,0)
 ;;=4^R87.611
 ;;^UTILITY(U,$J,358.3,33455,2)
 ;;=^5019669
 ;;^UTILITY(U,$J,358.3,33456,0)
 ;;=R87.610^^119^1580^3
 ;;^UTILITY(U,$J,358.3,33456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33456,1,3,0)
 ;;=3^ASC-US
 ;;^UTILITY(U,$J,358.3,33456,1,4,0)
 ;;=4^R87.610
 ;;^UTILITY(U,$J,358.3,33456,2)
 ;;=^5019668
 ;;^UTILITY(U,$J,358.3,33457,0)
 ;;=Z98.82^^119^1580^18
 ;;^UTILITY(U,$J,358.3,33457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33457,1,3,0)
 ;;=3^Breast Implant Status
 ;;^UTILITY(U,$J,358.3,33457,1,4,0)
 ;;=4^Z98.82
 ;;^UTILITY(U,$J,358.3,33457,2)
 ;;=^5063747
 ;;^UTILITY(U,$J,358.3,33458,0)
 ;;=B37.3^^119^1580^19
 ;;^UTILITY(U,$J,358.3,33458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33458,1,3,0)
 ;;=3^Candidiasis of Vulva & Vagina
 ;;^UTILITY(U,$J,358.3,33458,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,33458,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,33459,0)
 ;;=D06.9^^119^1580^20
 ;;^UTILITY(U,$J,358.3,33459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33459,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Unspec
 ;;^UTILITY(U,$J,358.3,33459,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,33459,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,33460,0)
 ;;=D06.0^^119^1580^21
 ;;^UTILITY(U,$J,358.3,33460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33460,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,33460,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,33460,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,33461,0)
 ;;=D06.1^^119^1580^22
 ;;^UTILITY(U,$J,358.3,33461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33461,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,33461,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,33461,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,33462,0)
 ;;=A56.02^^119^1580^23
 ;;^UTILITY(U,$J,358.3,33462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33462,1,3,0)
 ;;=3^Chlamydial Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,33462,1,4,0)
 ;;=4^A56.02
 ;;^UTILITY(U,$J,358.3,33462,2)
 ;;=^5000340
 ;;^UTILITY(U,$J,358.3,33463,0)
 ;;=N81.12^^119^1580^26
 ;;^UTILITY(U,$J,358.3,33463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33463,1,3,0)
 ;;=3^Cystocele,Lateral
 ;;^UTILITY(U,$J,358.3,33463,1,4,0)
 ;;=4^N81.12
 ;;^UTILITY(U,$J,358.3,33463,2)
 ;;=^331535
 ;;^UTILITY(U,$J,358.3,33464,0)
 ;;=N81.11^^119^1580^27
 ;;^UTILITY(U,$J,358.3,33464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33464,1,3,0)
 ;;=3^Cystocele,Midline
 ;;^UTILITY(U,$J,358.3,33464,1,4,0)
 ;;=4^N81.11
 ;;^UTILITY(U,$J,358.3,33464,2)
 ;;=^331534
 ;;^UTILITY(U,$J,358.3,33465,0)
 ;;=N81.10^^119^1580^28
 ;;^UTILITY(U,$J,358.3,33465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33465,1,3,0)
 ;;=3^Cystocele,Unspec
 ;;^UTILITY(U,$J,358.3,33465,1,4,0)
 ;;=4^N81.10
 ;;^UTILITY(U,$J,358.3,33465,2)
 ;;=^5015838
 ;;^UTILITY(U,$J,358.3,33466,0)
 ;;=R87.614^^119^1580^29
 ;;^UTILITY(U,$J,358.3,33466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33466,1,3,0)
 ;;=3^Cytologic Evidence of Malig on Smear of Cervix
 ;;^UTILITY(U,$J,358.3,33466,1,4,0)
 ;;=4^R87.614
 ;;^UTILITY(U,$J,358.3,33466,2)
 ;;=^5019672
 ;;^UTILITY(U,$J,358.3,33467,0)
 ;;=N87.9^^119^1580^36
 ;;^UTILITY(U,$J,358.3,33467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33467,1,3,0)
 ;;=3^Dysplasia of Cervix Uteri,Unspec
 ;;^UTILITY(U,$J,358.3,33467,1,4,0)
 ;;=4^N87.9
 ;;^UTILITY(U,$J,358.3,33467,2)
 ;;=^5015877
 ;;^UTILITY(U,$J,358.3,33468,0)
 ;;=R30.0^^119^1580^37
 ;;^UTILITY(U,$J,358.3,33468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33468,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,33468,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,33468,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,33469,0)
 ;;=N92.1^^119^1580^40
 ;;^UTILITY(U,$J,358.3,33469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33469,1,3,0)
 ;;=3^Excessive/Frequent Menstruation w/ Irregular Cycle
 ;;^UTILITY(U,$J,358.3,33469,1,4,0)
 ;;=4^N92.1
 ;;^UTILITY(U,$J,358.3,33469,2)
 ;;=^5015909
 ;;^UTILITY(U,$J,358.3,33470,0)
 ;;=Z08.^^119^1580^42
 ;;^UTILITY(U,$J,358.3,33470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33470,1,3,0)
 ;;=3^F/U Exam After Malig Neop Treatment
 ;;^UTILITY(U,$J,358.3,33470,1,4,0)
 ;;=4^Z08.
 ;;^UTILITY(U,$J,358.3,33470,2)
 ;;=^5062667
 ;;^UTILITY(U,$J,358.3,33471,0)
 ;;=Z80.3^^119^1580^43
 ;;^UTILITY(U,$J,358.3,33471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33471,1,3,0)
 ;;=3^Family Hx of Breast CA
 ;;^UTILITY(U,$J,358.3,33471,1,4,0)
 ;;=4^Z80.3
 ;;^UTILITY(U,$J,358.3,33471,2)
 ;;=^5063347
 ;;^UTILITY(U,$J,358.3,33472,0)
 ;;=Z80.49^^119^1580^44
 ;;^UTILITY(U,$J,358.3,33472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33472,1,3,0)
 ;;=3^Family Hx of Genital Organ CA
 ;;^UTILITY(U,$J,358.3,33472,1,4,0)
 ;;=4^Z80.49
 ;;^UTILITY(U,$J,358.3,33472,2)
 ;;=^5063351
 ;;^UTILITY(U,$J,358.3,33473,0)
 ;;=Z80.41^^119^1580^45
 ;;^UTILITY(U,$J,358.3,33473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33473,1,3,0)
 ;;=3^Family Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,33473,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,33473,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,33474,0)
 ;;=N73.9^^119^1580^48
 ;;^UTILITY(U,$J,358.3,33474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33474,1,3,0)
 ;;=3^Female Pelvic Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,33474,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,33474,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,33475,0)
 ;;=N60.32^^119^1580^49
 ;;^UTILITY(U,$J,358.3,33475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33475,1,3,0)
 ;;=3^Fibrosclerosis,Left Breast
 ;;^UTILITY(U,$J,358.3,33475,1,4,0)
 ;;=4^N60.32
 ;;^UTILITY(U,$J,358.3,33475,2)
 ;;=^5015780
 ;;^UTILITY(U,$J,358.3,33476,0)
 ;;=N60.31^^119^1580^50
 ;;^UTILITY(U,$J,358.3,33476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33476,1,3,0)
 ;;=3^Fibrosclerosis,Right Breast
 ;;^UTILITY(U,$J,358.3,33476,1,4,0)
 ;;=4^N60.31
 ;;^UTILITY(U,$J,358.3,33476,2)
 ;;=^5015779
 ;;^UTILITY(U,$J,358.3,33477,0)
 ;;=Z01.411^^119^1580^51
 ;;^UTILITY(U,$J,358.3,33477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33477,1,3,0)
 ;;=3^GYN Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,33477,1,4,0)
 ;;=4^Z01.411
 ;;^UTILITY(U,$J,358.3,33477,2)
 ;;=^5062622
 ;;^UTILITY(U,$J,358.3,33478,0)
 ;;=Z01.419^^119^1580^1
 ;;^UTILITY(U,$J,358.3,33478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33478,1,3,0)
 ;;=3
 ;;^UTILITY(U,$J,358.3,33478,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,33478,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,33479,0)
 ;;=Z01.419^^119^1580^52
 ;;^UTILITY(U,$J,358.3,33479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33479,1,3,0)
 ;;=3^GYN Exam w/ Normal Findings
 ;;^UTILITY(U,$J,358.3,33479,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,33479,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,33480,0)
 ;;=R87.613^^119^1580^54
 ;;^UTILITY(U,$J,358.3,33480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33480,1,3,0)
 ;;=3^HGSIL
 ;;^UTILITY(U,$J,358.3,33480,1,4,0)
 ;;=4^R87.613
 ;;^UTILITY(U,$J,358.3,33480,2)
 ;;=^5019671
 ;;^UTILITY(U,$J,358.3,33481,0)
 ;;=R87.612^^119^1580^64
 ;;^UTILITY(U,$J,358.3,33481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33481,1,3,0)
 ;;=3^LGSIL
 ;;^UTILITY(U,$J,358.3,33481,1,4,0)
 ;;=4^R87.612
 ;;^UTILITY(U,$J,358.3,33481,2)
 ;;=^5019670
 ;;^UTILITY(U,$J,358.3,33482,0)
 ;;=R92.1^^119^1580^68
 ;;^UTILITY(U,$J,358.3,33482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33482,1,3,0)
 ;;=3^Mammographic Calcification on Dx Breast Image
 ;;^UTILITY(U,$J,358.3,33482,1,4,0)
 ;;=4^R92.1
 ;;^UTILITY(U,$J,358.3,33482,2)
 ;;=^5019710
 ;;^UTILITY(U,$J,358.3,33483,0)
 ;;=R92.0^^119^1580^69
